/Elevance%20Health%20Inc%20laptop-by%20monticello%20via%20Shutterstock.jpg)
With a market cap of $102.5 billion, Elevance Health, Inc. (ELV) is a health benefits company offering a wide range of medical, pharmacy, and healthcare services across its four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It provides health plans, specialty insurance, pharmacy solutions, and healthcare management services under brands such as Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon.
The Indianapolis, Indiana-based company is expected to release its fiscal Q1 2025 earnings results before the market opens on Tuesday, Apr. 22. Ahead of this event, analysts expect ELV to report a profit of $10.97 per share, up 3.1% from $10.64 per share in the prior year's quarter. It has surpassed Wall Street's bottom-line estimates in three of the past four quarters while missing on another occasion. In Q4 2024, Elevance Health exceeded the consensus EPS estimate by 1.1%.